| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 0,0 € | — | — | — | — | — | — | — | — | — | |||||||||||||
| Gross margin | 1,6 M € | -26.2% | 2,2 M € | — | — | 2,5 M € | +0.7% | 2,4 M € | +139.6% | 1,0 M € | -4.3% | 1,1 M € | +57.6% | 673,9 k € | +1791.1% | 35,6 k € | +107.9% | -448,3 k € | -356.9% | 174,5 k € | +214.6% | -152,2 k € | ||||
| EBITDA | -2,0 M € | +22.0% | -2,5 M € | -19.2% | -2,1 M € | -14.8% | -1,8 M € | -131.9% | -789,3 k € | -17.1% | -674,0 k € | +65.1% | -1,9 M € | -19.6% | -1,6 M € | -54.2% | -1,0 M € | +6.6% | -1,1 M € | -54.8% | -724,3 k € | -4044.3% | -17,5 k € | +88.5% | -152,2 k € | |
| Operating profit | -19,5 M € | -607.4% | -2,8 M € | -12.8% | -2,5 M € | -7.8% | -2,3 M € | -97.6% | -1,2 M € | -11.6% | -1,0 M € | +54.4% | -2,3 M € | -19.6% | -1,9 M € | -54.8% | -1,2 M € | -0.5% | -1,2 M € | -27.0% | -956,1 k € | -4072.2% | -22,9 k € | +85.3% | -155,7 k € | |
| Profit/loss | -13,1 M € | -398.7% | -2,6 M € | -35.5% | -1,9 M € | +15.8% | -2,3 M € | -65.7% | -1,4 M € | -7.5% | -1,3 M € | +43.8% | -2,3 M € | -20.9% | -1,9 M € | -54.7% | -1,2 M € | -1.1% | -1,2 M € | -25.2% | -973,3 k € | -3539.3% | -26,7 k € | +82.8% | -155,8 k € | |
| Equity | 50,0 M € | -24.9% | 66,6 M € | +0.6% | 66,2 M € | +1.7% | 65,1 M € | +25.7% | 51,8 M € | +78.9% | 28,9 M € | +2.8% | 28,2 M € | -1.0% | 28,4 M € | +100.1% | 14,2 M € | +5.3% | 13,5 M € | +95.0% | 6,9 M € | +1294.1% | 496,6 k € | +16.8% | 425,1 k € | |
| Total assets | 85,3 M € | -6.9% | 91,5 M € | +14.1% | 80,3 M € | +10.4% | 72,7 M € | +18.4% | 61,4 M € | +26.7% | 48,5 M € | +23.2% | 39,3 M € | +13.6% | 34,6 M € | +93.3% | 17,9 M € | +10.5% | 16,2 M € | +99.2% | 8,1 M € | +725.6% | 985,3 k € | +101.2% | 489,7 k € | |
| Cash | 877,9 k € | +140.7% | 364,7 k € | -45.2% | 665,7 k € | -79.9% | 3,3 M € | -67.9% | 10,3 M € | +25.1% | 8,2 M € | -15.2% | 9,7 M € | -2.4% | 9,9 M € | +125.0% | 4,4 M € | -54.4% | 9,7 M € | +51.6% | 6,4 M € | +15781.9% | 40,2 k € | -79.0% | 191,5 k € | |
| Debts | 34,0 M € | +37.6% | 24,7 M € | +76.1% | 14,0 M € | +85.9% | 7,5 M € | -21.6% | 9,6 M € | -50.7% | 19,5 M € | +75.5% | 11,1 M € | +80.6% | 6,2 M € | +66.8% | 3,7 M € | +36.7% | 2,7 M € | +125.9% | 1,2 M € | +146.2% | 485,3 k € | +704.4% | 60,3 k € | |
| Staff | 39,3 | 45,6 | 39,5 | 37,8 | 39,3 | 41,4 | 39,6 | 36,3 | 25,4 | 15,1 | 3 | 3 | — | |||||||||||||
Public limited company · Mont-Saint-Guibert · incorporated on 31/05/2013 · 39,3 ETP
Public limited company loss-making in the latest fiscal year. Cash position rising (+140.7%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
NOVADIP BIOSCIENCES is a Public limited company incorporated in 2013. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Mont-Saint-Guibert. It employs on average 39,3 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette